A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
Clinical trial NCT04365036 · RECRUITING
Trial details
- NCT number
- NCT04365036
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-03
- Primary completion
- 2028-12-31
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.